91 Results

People

  1. Motzer
    Motzer
  2. Makker
    Makker
  3. Abou-Alfa
    Abou-Alfa
  4. Drilon
    Drilon
  5. Lee
    Lee
  6. Voss
    Voss
  7. Wong
    Wong
  8. Aghajanian
    Aghajanian
  9. Carlo
    Carlo
  10. Konner
    Konner

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)
  7. Radiology, Department of (12)
  8. Gastrointestinal Oncology Service (11)
  9. Center for Pancreatic Cancer Research (9)
  10. Weinberg Fellows (9)
  1. "lenvatinib"
Formats
  1. Journal Article (58)
  2. Review (19)
  3. Editorial (3)
  4. Guidelines (3)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Meeting Abstract (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)

More Groups

People
  1. Robert Motzer (25)
  2. Vicky Makker (16)
  3. Ghassan Abou-Alfa (9)
  4. Chung-Han Lee (7)
  5. Alexander Drilon (4)
  6. Martin Voss (4)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Urology (5)
  2. Cancers (4)
  3. The Oncologist (4)
  4. Annals of Oncology (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Gastrointestinal Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. Elsevier Science, Inc. (8)
  3. Oxford University Press (8)
  4. MDPI (4)
  5. Nature Publishing Group (4)
  6. Wiley Blackwell (4)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Elderly patients with metastatic renal cell carcinoma: Position paper from the International Society of Geriatric Oncology
    Journal Article

    Kanesvaran, R.; Le Saux, O.; Motzer, R.; Choueiri, T. K.; Scotté, F.; Bellmunt, J.; Launay-Vacher, V.
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Targeting RET-driven cancers: Lessons from evolving preclinical and clinical landscapes
    Journal Article

    Drilon, A.; Hu, Z. I.; Lai, G. G. Y.; Tan, D. S. W.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Incidence and timing of common adverse events in lenvatinib-treated patients from the SELECT trial and their association with survival outcomes
    Journal Article

    Haddad, R. I.; Schlumberger, M.; Wirth, L. J.; Sherman, E. J.; Shah, M. H.; Robinson, B.; Dutcus, C. E.; Teng, A.; Gianoukakis, A. G.; Sherman, S. I.
    Endocrine (2017)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Journal Article

    Lee, C. H.; Hötker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K. M.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J. J.; Motzer, R. J.
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • New and emerging therapeutic options for thyroid carcinoma
    Journal Article

    Shah, J. P.; Clayman, G. L.; Wirth, L. J.
    Clinical Advances in Hematology & Oncology (2015)

    Fulltext@MSK | Save
  • The use of genetic alterations in the development of liver cancer drugs
    Journal Article

    Abou-Alfa, G. K.
    Clinical Advances in Hematology & Oncology (2015)

    Fulltext@MSK | Save
  • Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
    Journal Article

    Puzanov, I.; Amaravadi, R. K.; McArthur, G. A.; Flaherty, K. T.; Chapman, P. B.; Sosman, J. A.; Ribas, A.; Shackleton, M.; Hwu, P.; Chmielowski, B.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Therapy: Lenvatinib and radioiodine-refractory thyroid cancers
    Journal Article

    Dunn, L.; Fagin, J. A.
    Nature Reviews Endocrinology (2015)

    Fulltext@MSK | Save
  • Molecularly targeted therapies in non-small-cell lung cancer annual update 2014
    Journal Article

    Morgensztern, D.; Campo, M. J.; Dahlberg, S. E.; Doebele, R. C.; Garon, E.; Gerber, D. E.; Goldberg, S. B.; Hammerman, P. S.; Heist, R. S.; Hensing, T.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
    Journal Article

    Molina, A. M.; Hutson, T. E.; Larkin, J.; Gold, A. M.; Wood, K.; Carter, D.; Motzer, R.; Michaelson, M. D.
    Cancer Chemotherapy and Pharmacology (2014)

    Fulltext@MSK | Save